Department of Neurology, Lanzhou University Second Hospital, Cuiyingmen 82, Chengguan District, Lanzhou, Gansu 730030, China.
Department of Neurology, Wuwei people's Hospital, North side of Xuanwu Street, Liangzhou District, Wuwei, Gansu 733000, China.
J Neuroimmunol. 2023 Aug 15;381:578108. doi: 10.1016/j.jneuroim.2023.578108. Epub 2023 May 16.
Ischemic stroke (IS) is a leading cause of morbidity and mortality worldwide. Immunity and inflammation are key factors in the pathophysiology of IS. The inflammatory response is involved in all stages of stroke, and microglia are the predominant cells involved in the post-stroke inflammatory response. Resident microglia are the main immune cells of the brain and the first line of defense of the nervous system. After IS, activated microglia can be both advantageous and detrimental to surrounding tissue; they can be divided into the harmful M1 types or the neuro-protective M2 type. Currently, with the latest progress of transcriptomics analysis, different and more complex phenotypes of microglia activation have been described, such as disease-related microglia (DAM) associated with Alzheimer's disease (AD), white matter associated microglia (WAMs) in aging, and stroke-related microglia (SAM) etc. The triggering receptor expressed on myeloid cell 2 (TREM2) is an immune-related receptor on the surface of microglia. Its expression increases after IS, which is related to microglial inflammation and phagocytosis, however, its relationship with the microglia phenotype is not clear. This paper reviews the following: 1) the phenotypic changes of microglia in various pathological stages after IS and its relationship with inflammatory factors; 2) the relationship between the expression of the TREM2 receptor and inflammatory factors; 3) the relationship between phenotypic changes of microglia and its surface receptor TREM2; 4) the TREM2-related signalling pathway of microglia after IS and treatment for TREM2 receptor; and finally 5) To clarify the relationship among TREM2, inflammation, and microglia phenotype after IS, as well as the mechanism among them and the some possible treatment of IS targeting TREM2. Moreover, the relationship between the new phenotype of microglia such as SAM and TREM2 has also been systematically summarized, but there are no relevant research reports on the relationship between TREM2 and SAM after IS.
缺血性脑卒中(IS)是全球范围内发病率和死亡率的主要原因。免疫和炎症是 IS 病理生理学的关键因素。炎症反应涉及中风的所有阶段,小胶质细胞是中风后炎症反应的主要细胞。驻留小胶质细胞是大脑的主要免疫细胞,也是神经系统的第一道防线。在 IS 后,激活的小胶质细胞对周围组织既有好处也有坏处;它们可以分为有害的 M1 型或神经保护的 M2 型。目前,随着转录组分析的最新进展,已经描述了小胶质细胞激活的不同和更复杂的表型,例如与阿尔茨海默病(AD)相关的疾病相关小胶质细胞(DAM)、衰老相关的白质小胶质细胞(WAMs)和与中风相关的小胶质细胞(SAM)等。髓样细胞表达的触发受体 2(TREM2)是小胶质细胞表面的一种免疫相关受体。其在 IS 后表达增加,与小胶质细胞炎症和吞噬作用有关,但与小胶质细胞表型的关系尚不清楚。本文综述了以下内容:1)IS 后各病理阶段小胶质细胞的表型变化及其与炎症因子的关系;2)TREM2 受体表达与炎症因子的关系;3)小胶质细胞表型变化与其表面受体 TREM2 的关系;4)IS 后小胶质细胞的 TREM2 相关信号通路及 TREM2 受体治疗;最后 5)阐明 IS 后 TREM2、炎症与小胶质细胞表型之间的关系及其机制,以及针对 TREM2 的 IS 可能的治疗方法。此外,还系统总结了 IS 后小胶质细胞等新表型与 TREM2 的关系,但 IS 后 TREM2 与 SAM 之间的关系尚无相关研究报道。